27–28 May 2026 | Doltone House Hyde Park
Summit program at a glance
Our full-day summit offers a mix of insightful sessions, networking opportunities, and industry highlights. Attendees can choose from Full Registration or Luncheon-Only options.
Day 1 | 9:00 AM – 5:30 PM
Full Day program with keynotes, panel discussions and networking breaks
Â
Welcome Reception | 5:30 PM – 6:30 PM
Full registration required for all Day 1 sessions and the Welcome Reception.
Day 2 | 9:00 AM – 12:15 PM
Morning Sessions + Spotlight on Women’s Health Innovations with Q&A and Networking
Exclusive to Full Registration attendees.
Â
Day 2 | 12:15 PM – 2:30 PM
Women’s Health Luncheon
Sit-down luncheon bringing together the Summit audience and broader community to hear from a special guest speaker (details to be announced)
Luncheon is included for Full Registration attendees.
9.00am
15 mins
Introduction (MC)​
Jasjit Baveja is Director of Regulatory and Industry Policy at MTAA, where she leads regulatory policy development and industry engagement with the Therapeutic Goods Administration. She brings over a decade of hands-on experience in medical device regulation.
A long-standing advocate for women in the medical technology industry, Jasjit has co-led women’s network employee resource groups at both Boston Scientific and Johnson & Johnson, and continues to champion gender diversity and inclusion across the sector through her work at MTAA.
Welcome to Country
Uncle Michael West from Metropolitan Local Aboriginal Land Council.
A member of the Stolen Generations.
Born raised and lived his whole life in the Sydney community.
Cultural Educator and practicing artist.
First Aboriginal person in computing science.
Use what you think will fit in form below contextually.
Michael has had a variety of previous roles
• Director – NSW Indigenous Chamber of Commerce
• Director – Australian Communications Consumer Action Network (ACCAN)
• Co-Chair – National Sorry Day Committee
• Delegate – National Congress of Australia’s First Peoples
• Aboriginal & Torres Strait Islander Advisory Committee to the Board of
Headspace
• Aboriginal & Torres Strait Islander Advisory Group Australian Curriculum
Assessment Reporting Authority
• Cultural Advisor Tedx Sydney
9.15am
15 mins
Welcome and Official Opening, MTAA
Ian is CEO of the Medical Technology Association of Australia, the peak national association representing companies in the medical device industry.
Ian’s previous CEO roles have included commercial health organisations and also medical professional associations – the Australian Dental Association (NSW) and the Australian Orthopaedic Association.
Ian holds an MBA from Macquarie University and a Bachelor of Economics from the Australian National University, and he is a member of the Australian Institute of Company Directors.
Ian is also a non-executive director of Red Nose, formerly known as SIDS & Kids, a well-respected not-for-profit organisation that is dedicated to saving the lives of babies and children.
9.30am
30 mins
1
Opening Keynote
Gabrielle Jackson is deputy editor at Guardian Australia, where she has worked since 2014. She was previously head of multimedia and was an associate editor for news and opinion editor before that. She is the author of Pain and Prejudice: How the Medical System Ignores Women and What We Can Do About It, which has been published in Australia, New Zealand, United Kingdom, Ireland, United States, Canada and China and optioned for a documentary. She won the 2016 National Medicinewise Award for her reporting on endometriosis.
10.05am
45 mins
2
Global Perspective Panel
![RN Photo April 2026[1] (1)](https://www.womenshealthmedtechsummit.org.au/wp-content/uploads/2026/05/RN-Photo-April-20261-1-300x300.jpg)
Robyn Norton AO FAHMS is one of the two Founding Directors of The George Institute for Global Health, Professor of Public Health at UNSW Sydney and Emeritus Professor of Global Health at Imperial College London. Robyn co-established The George Institute’s Global Women’s Health Program and more recently the Centre for Sex and Gender Equity in Health and Medicine, where she co-leads the Business Translation Working Group. Robyn is a director on the board of the Black Dog Institute, a member of the Women in MedTech Committee of the MTAA and a member of Chief Executive Women. She also chairs the NHMRC’s Gender Guidelines Development Committee and the Advisory Board of the Network of Excellence in Women’s Health at Imperial College London.
Dr Talia Avrahamzon is a dedicated advocate for equity, working at the intersection of policy, innovation, and impact within Australia’s health and medical research sector. As the Head of Policy at Research Australia, the national health and medical research and innovation peak, she contributes to advancing a more inclusive and equitable research ecosystem through evidence-based policy and advocacy. She is particularly passionate about reducing disparities in health outcomes through research equity and ensuring marginalised populations are meaningfully represented in research design, funding priorities, and innovation (translation and commercial) pathways as well as in the organisations undertaking the work.
With over 20 years experience in federal government, academia and not-for-profit sectors, Talia has led large reform agendas across policy, data, and research that centre on systems level responses to addressing intersectional discrimination (including in gender, racism and ableism, and place). Talia is committed to evidence-based decision-making, and sharing learnings from other sectors to build a more inclusive, equitable, responsive health and medical research ecosystem, health outcomes, and social and economic participation.
Aggie Cox is the Marketing Director for ANZ at Hologic, a global leader in medical technology focused on advancing women’s health. Her journey began as a registered nurse, where she developed a deep understanding of patient needs and the critical role of healthcare innovation. This foundation gives her a unique perspective that bridges clinical expertise with strategic marketing leadership. With over two decades of experience across medical devices, diagnostics, and pharmaceuticals. She combines strategic business acumen, clinical insight, and marketing expertise to drive initiatives that accelerate brand growth, deepen customer engagement, and expand market presence across the region. A passionate advocate for women’s health, Aggie draws on her personal and professional experience, along with insights from the Hologic Global Women’s Health Index, to spotlight critical challenges women face and spark conversations that inspire change. Her guiding mantra is: “Data tells the story, but people give it meaning.”
Dr Olena Ivanova is a Senior Research Fellow at the SPHERE Centre of Research Excellence with a PhD in Health Sciences, a medical degree, and a Master’s in Public Health from leading European institutions. Her international, multidisciplinary research focuses on advancing equity and innovation in sexual and reproductive health. Olena is the founder of Women’s Health & FemTech Ukraine, co-founder and board member of FemTech Germany, and creator of SxRx Collective in Australia. She drives change through evidence-based research, community building, and strategic advisory, and was named one of the 200 Trailblazing Leaders in Women’s Health and FemTech by Women of Wearables.
10.50am
Morning Tea
11.20am
30 mins
3
Lived Experience Keynote
Jen O’Neill is a Social Work Program Manager and mother of two from the Central Coast, NSW. At 36, she experienced her first spontaneous coronary artery dissection (SCAD) heart attack and has since survived two further SCADs before age 43. Her lived experience has driven a strong commitment to heart health advocacy, focusing on improving education, research, and clinical understanding of cardiovascular disease in women without typical risk factors. Jen is a board member of SCAD Research Australia and serves on the Women’s Health Program Consumer Panel at The George Institute for Global Health. She is an ambassador for Heart Research Australia’s Red Feb campaign and participates in studies including with the Victor Chang Cardiac Research Institute and Mayo Clinic. She also supports community fundraising initiatives, including the Central Coast SCADaddle for Research Walk. She is recognised for leadership in advocacy and advancing cardiovascular health informed by lived experience.
11.55am
5 mins
4
Ministerial Video Address – The Hon. Rebecca White MP, Assistant Minister for Health and Aged Care, Assistant Minister for Indigenous Health, Assistant Minister for Women
12.00pm
40 mins
5
TGA insights
Professor Langham is the Chief Medical Adviser of the Therapeutic Goods Administration in Australia. She is a nephrologist and clinician researcher, focusing on drug development of novel anti-inflammatory and anti-fibrotic agents. Professor Langham is also a director of the Australian Medical Council and chairs the Human Research and Ethics Committee at the Royal Children’s Hospital in Melbourne.
Tracey Duffy is the First Assistant Secretary of the Medical Devices and Product Quality Division in Therapeutic Goods Administration (TGA). Her current responsibilities include the regulation of Medical Devices, Good Manufacturing Practices and Laboratory testing. Tracey was the former Chair of the International Medical Device Regulators Forum, and Chair of Medical Device Single Audit Program Regulatory Authority Council. She has chaired a number of international and national working groups and has held several leadership roles within the Department of Health, Ageing and Disability. She also has private sector experience including consultant advisory roles.
12.45pm
Lunch
1.30pm
45 mins
6
Clinically Proven, But for Whom?
- When the default body is male, the evidence can be incomplete.
Leanne Weekes is the Director of Research and Policy at Bellberry Limited. Her work focuses on advancing ethics, policy, and sector-wide initiatives, including thought leadership, aimed at strengthening Australia’s clinical trials sector.
Prior to joining Bellberry, Leanne established and led Clinical Trials: Impact & Quality (CT:IQ), an MTPConnect-funded initiative that brought together the clinical trials sector to develop and implement recommendations to improve impact, quality, and efficiency.
She has over 12 years of experience in biopharma research and development, managing clinical trials and programs for pharmaceutical companies and CRO’s across Australia, New Zealand, the UK, and Europe. Earlier in her career, Leanne worked in pre-clinical drug and diagnostic development for Australian and US biotechnology start-ups, having begun her career in bench research.
Leanne holds a first-class Honours degree in Pathology and a first-class Master’s degree in Public Health.
Ms Prue Torrance (she/her) is the General Manager and Chief Operating Officer at the National Health and Medical Research Council (NHMRC). She has extensive leadership experience in science and research policy and programs, as well as having held senior public service management roles in corporate governance and finance. She holds a Master of Studies (Public Policy) from the Australian National University and a Bachelor of Arts (Hons in Political Philosophy) and Science (Psychology).
Bronwyn Graham is a Professor in the School of Psychology at UNSW Sydney and the inaugural Director of the Centre for Sex & Gender Equity in Health & Medicine at the George Institute for Global Health. A clinical psychologist and behavioural neuroscientist, Bronwyn has dedicated her career to improving women’s mental health by researching how the female brain regulates emotions and translating the findings to clinical settings and beyond. At the Centre for Sex & Gender Equity, Bronwyn’ team has led policy changes to improve the quality of medical research and healthcare by accounting for the influence of sex and gender on health outcomes. Bronwyn is funded by the Australian Research Council, the National Health and Medical Research Council, the Wellcome Trust Foundation, and she has held numerous national and international fellowships. She has published over 80 peer-reviewed research articles and chapters, and supervised over 40 honours and postgraduate students.
Associate Professor Cheryl Carcel is the Head of the Brain Health Program at The George Institute for Global Health. She also works part-time as a clinical neurologist. Cheryl is an NHMRC Emerging Leader Fellow and a World Stroke Organization co-chair for the scientific statement on Sex Differences in Stroke.
A/Prof Carcel’s research focuses on health equity, in particular working on sex and gender differences, women’s brain health and policies encouraging disaggregation of data by sex and gender.
A/Prof Fiona Brownfoot (MBBS, FRANZCOG, PhD) is a clinician scientist, an obstetrician at the Mercy Hospital for Women and the Epworth Freemasons and a laboratory trained scientist at The University of Melbourne. She co-founded start-up Kali Healthcare and is the CMO and COO. Kali Healthcare is focused on delivering a fetal monitoring platform, wearable device with AI diagnostics to better detect pregnancy complications and bring more mothers and babies safely home. She has authored over 85 publications in journals including BMJ, Nature’s npj Digital Medicine, American journal of Obstetrics and Gynaecology among others and has been the CI on research grants over $13 million and commercial grants over $2.6 million. She has received national and international awards for her work and given numerous invited presentations.
2.20pm
45 mins
7
Designed without Her – Designing for the Outcomes We Want
Rozalina Sarkezians is the Managing Director and Editor-in-Chief of Health
Industry Hub which unites the diversity of the MedTech, Pharma, Diagnostics & Biotech sectors to inspire meaningful change. She is the first female founder of industry media, merging her unique clinical experience, scientific acumen, and industry expertise of 20+ years. She currently serves on the Australian Patient Advocacy Alliance (APAA) and Pain Australia working groups, in addition to mentoring STEM PhD students who are keen to transition into industry careers.
Annette, an Orthopaedic and Trauma surgeon is the Clinical Director of Surgery and Peri-operative Services in the Royal Australian Air Force, having recently completing roles a Councillor at the Royal Australasian College of Surgeons, Governor of the Shrine of Remembrance in Melbourne and Past President of the Australian Orthopaedic Association in 2022.
Annette was one of the first two women undertaking orthopaedic training in Australia in 1986. Initially practised broadly with a special interest in Paediatric Orthopaedics, she transitioned via two years of Fellowship to a focus on Trauma Surgery. Her clinical work has been across Melbourne and Darwin, with stints away as a first responder in disasters both as a civilian and in uniform, to war zones and on Peacekeeping missions.
In 2019 she was elected by the membership to the Australian Orthopaedic Association Presidential line, becoming the first female on that line and President in November 2021.
She has been on the forefront of driving change in Orthopaedics to be more understanding and accepting of women contributing to the profession.
Associate Professor Claudia Di Bella is a Melbourne-based orthopaedic surgeon with subspecialty expertise in orthopaedic oncology. She completed her training at the Rizzoli Orthopaedic Institute in Bologna, Italy, and holds a PhD in oncology and experimental pathology.
A/Prof Di Bella is recognised for her expertise in the management of complex musculoskeletal tumours and her commitment to multidisciplinary, patient-centred care, alongside advancing surgical innovation in the field.
A/Prof Di Bella holds leadership roles across national and international sarcoma organisations and is a strong advocate for diversity, equity and inclusion, with a particular commitment to supporting and advancing women in surgery.
Dr Michelle M. Hill is a biomedical researcher and entrepreneur translating cutting-edge proteomics into clinical diagnostics for women’s health. She is the Founder and CEO of Proseek Bio, where she leads pioneering development of blood biomarker panel-based tests for ovarian cancer.
Michelle has an h-index of 53 with over 10,000 citations, and her work has contributed to the discovery and clinical translation of novel cancer biomarkers. She has led multidisciplinary programs spanning biomarker discovery, technology platforms, industry collaborations, and clinical implementation.
A graduate of the prestigious CSIRO ON Accelerate program, Michelle is also a strong advocate for fostering the next generation of female scientists and entrepreneurs. She is committed to advancing inclusive innovation and supporting pathways for women to lead in science and biotech commercialization.
Prof Mukherjee is an Adult and Paediatric ENT surgeon in Sydney subspecialising in hearing and balance disorders, Cochlear Implants and the lateral Skull base tumours. Her research specialises in ear bionics using 3D bioprinting. Awarded the prestigious RACS Michael Donellan medal for outstanding contribution to the art and science of surgery and a Eureka prize finalist for interdisciplinary research in 2022, she has a passion for global translation of Australian innovation in biotechnology. She is Royal Australasian College of Surgeons councillor, Chair of the RACS, Section of Academic Surgery and ASERNIPS (Australian Safety and Efficacy register of new interventional disorders), co-director of an NSW based innovation program called Beyond Science that supports early career researchers, an expert panel of the Medical Devices fund, NSW health and a past committee member of the Advisory Committee of Therapeutic Goods Administration. She is passionate about gender equity in Surgery as well as developing STEM skills in young girls. She was awarded a Women in Surgery Leadership award in 2022 and was finalist of the NSW Premier Women of the year award in 2019.
3.10pm
Afternoon Tea
3.40pm
20 mins
8
The Information Gap When research, trust, and reality do not align
Dr Sarah White is Chief Executive Officer of Jean Hailes for Women’s Health, Australia’s leading non-profit provider of women’s health information. Prior to Jean Hailes, Dr White headed Quit, Australia’s most comprehensive tobacco control program and, for more than a decade, led science and health communications teams in Melbourne and New York.
Dr White is a member of the Therapeutic Goods Administration’s Women’s Health Products Working Group and the Victorian Women’s Health Advisory Council, and was a member of Australia’s former National Women’s Health Advisory Council.
Dr White has extensive experience in advocacy, communications, consumer engagement, policy development, program management, research translation, government relations and media relations. She is applying this experience to further Jean Hailes’ work to provide practical, accessible, evidence-based information to improve the health and wellbeing for all Australian women and girls.
4.00pm
10 mins
9
Case Study 1 – FDA Pathway, De Novo
Sam brings with him a wealth of experience spanning across both clinical and commercial expertise having worked as a clinician and also as commercial operator across the region. He is passionate about improving outcomes through innovative products and processes. He is currently focused on introducing an innovative product that can enhance antenatal care into Australia and the surrounding region.
4.15pm
10 mins
10
Case Study 2 – FDA Pathway, Breakthrough Designation
With 20+ years in MedTech leadership, Tara leads the development and scaling of AI-enabled, wearable technologies in women’s health, with a focus on maternal and fetal care. As CEO of Baymatob, she has guided the company from early-stage development through clinical validation and growth, building a mission-driven organisation addressing a critical gap in healthcare.
She has a strong track record in securing dilutive and non-dilutive funding across venture, grants, and strategic partnerships, and brings experience in commercialising digital health products and scaling businesses.
Tara has deep expertise in global regulatory pathways, including U.S. FDA engagement, and has led regulatory and quality strategies supporting clinical trials, market approval, and international expansion.
She is committed to advancing innovation in women’s health and translating technology into strong commercial entities, alongside meaningful outcomes commercial for mothers and babies worldwide.
Credentials: GAICD, MBA, B. Engineering, B. Medical Science
4.25pm
10 mins
11
Fast-track Her – The Case for a Women's Health Priority Pathway
Susannah Rooney is the Founder and Executive Director of Amplify51 and a respected executive with a strong track record in leading organisational transformation and scaling operations. Since 2020 she held senior leadership positions at Victor Chang Cardiac Research Institute, gaining comprehensive expertise in the medical research sector and a deep understanding of the funding and policy frameworks shaping women’s health in Australia. With a background in law and management, Susannah is recognised for her people-focused, inclusive leadership driven by vision, integrity, and a commitment to excellence. Founding Amplify51 in 2026, she is building collaborative communities and advocating for greater investment in women’s health by researching proven strategies implemented internationally and leveraging evidence-based data to highlight its high impact and growth potential. Her goal is to influence national conversations and drive investment in women’s health, accelerating systemic change to improve outcomes.
Falko Thiele is a senior medical technology executive with more than 30 years of global experience across R&D, marketing, business development, regulatory affairs, and clinical research. He holds a Master of Science in Biomedical Engineering from the University of Virginia and an MBA from Anglia Ruskin University, Cambridge (UK).
As Director of Clinical and Regulatory Affairs for BIOTRONIK Australia, Falko leads regional clinical strategy and regulatory operations for advanced cardiovascular technologies, including pacemakers, defibrillators, and electrophysiology solutions.
Falko is a long‑standing member of the Medical Technology Association of Australia (MTAA) Regulatory Affairs Committee and co‑chair of its Clinical Investigations Forum.
He is passionate about enabling equitable, timely access to innovative medical technologies and improving health outcomes for diverse patient populations.
4.40pm
40 mins
12
Half the Population, Fraction of the Funding – How reimbursement shapes Women’s Health innovation
Helen has a BA in Statistics and Computer Science and over 20 years of commercial expertise spanning FMCG, digital innovation, MedTech, Biotech, and digital health.
As CEO of Cardihab, Helen is focused on delivering innovative solutions that harness the power of technology and data to improve outcomes for patients and healthcare professionals.
She is a strong advocate for evidence-based digital health innovations that support the growth of the Australian digital health ecosystem.
Helen also serves as a Board Member of the Medical Technology Association of Australia (MTAA) and is the Chair of the MTAA Digital Health Advisory Group (DHAG).
Dr Shona Sundaraj MBBS, FRACGP, BAppSc (Phty), MBA
Shona is the Group Medical Director of Medibank and brings a senior clinical lens to thought leadership, strategy and advocacy. She also leads the Medibank Better Health Research Hub and chairs Medibank’s Health Research Governance Committee, providing grant funding to multiple universities, translational research facilities and peak professional bodies.
Her passion is healthy ageing which begins at birth and continues at all ages. This is the driver and lens that she uses for her systems approach to healthcare as a senior leader at Medibank.
Shona has a 20+ year understanding of the Australian health ecosystem initially as a Physiotherapist then General Practitioner. She is a Fellow of the Royal Australian College of General Practitioners. Shona completed her MBA through Imperial College London Business School. She is a non-executive director and regular invited speaker.
Shona is a Sydney native. She is a mother of 2 beautiful kids and enjoys running and walking her 2 dogs along Sydney’s harbour and beaches.
Dr Ceri Cashell is a UK-trained GP based in Sydney and co-founder of Healthy Hormones, the world’s only menopause app integrating clinician education, real-time support and a rapidly growing public community in one digital ecosystem.
Struck by the gender gap in medical research and her own lack of menopause training, she built the platform to do what the system hadn’t. Today Healthy Hormones upskills thousands of clinicians through AI-enabled learning and multidisciplinary support, while empowering women with evidence-based information and access to menopause-trained providers: free for both.
Dr Ceri is a speaker, educator, researcher and advocate, working to ensure Australian women are no longer the casualties of a healthcare system not designed with them in mind.
Anabela is a healthcare venture builder and operator with expertise in scaling medical technologies from innovation to global commercial revenue.
She is the Founder and Managing Director of Inner Maven, a healthcare commercialisation and growth firm working alongside founders, leadership teams and investors to drive commercial execution and scale across diagnostics, devices, therapeutics and digital health.
Anabela also serves as Australian Director for Sweef Capital, a global gender-lens investment platform focused on backing sustainable and female-led businesses across Asia-Pacific.
With a background spanning medicine, venture capital and commercial strategy, Anabela focuses on translating healthcare technologies into commercially viable and investible businesses.
5.25pm
10 mins
Day 1 Closing Remarks
Jasjit Baveja is Director of Regulatory and Industry Policy at MTAA, where she leads regulatory policy development and industry engagement with the Therapeutic Goods Administration. She brings over a decade of hands-on experience in medical device regulation.
A long-standing advocate for women in the medical technology industry, Jasjit has co-led women’s network employee resource groups at both Boston Scientific and Johnson & Johnson, and continues to champion gender diversity and inclusion across the sector through her work at MTAA.
5.35pm
Welcome Reception
7:30pm
Day 1 End
9:00am
15mins
Day 2 Welcome
Jasjit Baveja is Director of Regulatory and Industry Policy at MTAA, where she leads regulatory policy development and industry engagement with the Therapeutic Goods Administration. She brings over a decade of hands-on experience in medical device regulation.
A long-standing advocate for women in the medical technology industry, Jasjit has co-led women’s network employee resource groups at both Boston Scientific and Johnson & Johnson, and continues to champion gender diversity and inclusion across the sector through her work at MTAA.
9.15am
30 mins
13
Day 2 Keynote
Sponsored
by Smith &
Nephew
Robyn Norton AO FAHMS is one of the two Founding Directors of The George Institute for Global Health, Professor of Public Health at UNSW Sydney and Emeritus Professor of Global Health at Imperial College London. Robyn co-established The George Institute’s Global Women’s Health Program and more recently the Centre for Sex and Gender Equity in Health and Medicine, where she co-leads the Business Translation Working Group. Robyn is a director on the board of the Black Dog Institute, a member of the Women in MedTech Committee of the MTAA and a member of Chief Executive Women. She also chairs the NHMRC’s Gender Guidelines Development Committee and the Advisory Board of the Network of Excellence in Women’s Health at Imperial College London.
9.50am
40 mins
14
A Workforce Issue, Not a Women's Issue – From Awareness to Advantage
Turning women’s health at work into a performance advantage. This session makes the business case – linking awareness and smart accommodations to productivity, retention and outcomes – and shares what good support looks like in practice.
Dr Melina Georgousakis is an academic, social entrepreneur and governance-experienced leader with over a decade of experience across the Australian health and medical research ecosystem.
Melina’s experience spans research, policy, philanthropy and entrepreneurship, giving her a strong understanding of how ideas are funded, scaled and connected with government and community priorities. Her work has focused on strengthening workforce capability, driven by a commitment to building an ecosystem that values diverse experiences and perspectives which enables innovation and impact.
She is the Founder and former Director of Franklin Women, a national social enterprise advancing women’s representation and participation across the health and medical research ecosystem. Under her leadership the organisation delivered national impact supporting more than 1,000 members and partnering with 27 organisations in a shared mission to drive systemic change.
Melina holds a PhD and a Master of Public Health and has completed the McKinsey Executive Leadership Program. She has served as a judge for the Australian Museum Eureka Awards and the Australian Technologies Competition, and her work has been recognised through several awards.
Nicki Luther is Senior Director of Human Resources at Stryker, where she leads enterprise people strategy across the South Pacific region. With more than 22 years’ experience in human resources and having been with Stryker since 2012, Nicki partners closely with senior leaders to align people, culture, and capability with commercial outcomes.
Stryker is a Fortune 500 medical technology company with revenues exceeding US$20 billion, driven by a clear purpose of making healthcare better. Employing over 50,000 people globally, the organisation is known for its strong culture and sustained recognition as one of Australia’s Best Workplaces.
Working in a business where talent is core to strategy, Nicki is passionate about strengths-based leadership and building systems that enable leaders and teams to perform at their best. Her work focuses on scaling impact through leadership capability, pragmatic people strategy, and culture that drives results. Nicki has featured on Gallup’s Called to Coach podcast and Theme Thursday (Developer Season 3), sharing insights on strengths-based leadership in complex organisations.
Gillian Scott is Associate Director, Human Resources for ANZ at Vantive, a leading vital organ therapy organisation focused on extending lives and expanding possibilities for patients worldwide. With deep experience partnering across commercial, functional, and supply chain teams, Gillian brings a practical, people centred approach to enabling performance, capability, and sustainable growth.
She is recognised for her work in leadership development, talent strategy, and organisational transformation, supporting leaders to translate strategy into meaningful employee experiences. Gillian is particularly passionate about building strong performance cultures through clear goals, effective check ins, and inclusive leadership practices.
Based in Sydney, she works across the Asia Pacific region and, outside of work, can often be found curiously people watching, laughing with friends, travelling near and far, enjoying good food and wine, or indulging her love for pub choir—bringing the same energy and warmth to life as she does to leadership.
Catherine (Cat) is a senior HR Professional with over twenty years HR experience across a diverse range of industries and workplace cultures including Medical Devices, Telecommunications and Hospitality.
Highly collaborative with a proven track record as a strategic partner and program leader, Cat is adept in building trusting partnerships at the leadership level across multiple stakeholders and domains.
Globally orientated with professional experience in the UK and Australia and Program Management experience across Asia Pacific, Cat’s passion partnering with the business to drive innovative and equitable talent strategies that result in a highly engaged and high performing culture within Medtronic. Cat is also a highly committed and effective in driving Inclusion, Diversity & Equity programs with a goal to create the best and most inclusive environment to work for all.
Associate Professor Talat Uppal is a distinguished gynaecologist and the Director of Women’s Health Road, where she pioneered an integrated, multidisciplinary care model. A specialist in Abnormal Menstrual Bleeding (AUB), she founded Australia’s first AUB Management Hub and established the “Bleed Better” initiative, creating International Heavy Menstrual Bleeding Day (May 11th).
Currently a Clinical Associate Professor at Macquarie University and consultant at Macquarie Hospital, her career includes over a decade as Clinical Director at Manly and Mona Vale Hospitals. Dr. Uppal is a Fellow of both the AAQHC and ACHSM and received the RANZCOG Conspicuous Service Medal in 2018 for her contributions to GP education.
A prominent advocate for digital health, she serves as an ambassador for REMIE Australia and represents RANZCOG on SPARKED.au. Through media, podcasts, and clinical education, she remains dedicated to improving women’s health outcomes, particularly regarding heavy bleeding, iron deficiency, and menopause management.
10.30am
Morning Tea & Networking
11.30am
45 mins
15
Momentum in Motion - Women’s health innovation gaining ground
Real-world innovation, straight from the founders. Hear short case studies of emerging women’s health technologies – what’s working, what’s hard, and what it takes to get from prototype to adoption. A high-energy bridge into the Women’s Health MedTech Summit Luncheon and networking.
Dina Titkova works at the intersection of innovation and entrepreneurship, with over 15 years’ experience across partnerships and venture development in Australia and Europe. At UNSW Founders, she leads the team delivering the university’s flagship startup incubators and accelerator programs.
A strong advocate for health equity, Dina launched the Health 10x program in partnership with The George Institute for Global Health, backing innovations addressing major unmet health needs. In 2023, she established the first Women’s Health Accelerator in APAC within Health 10x. Under her leadership, the program has supported over 250 startups and invested in 40, with a growing share focused on women’s health across conditions that affect women uniquely or disproportionately.
Dr Ariella Heffernan-Marks is the CEO and Founder of Ovum, a pioneering health partner built for women dedicated to transforming women’s healthcare experiences through artificial intelligence. Dr Heffernan-Marks holds a Doctor of Medicine from Macquarie University and a Bachelor of Science in Reproductive Biology and Embryology. She is currently undertaking a PhD in FemTech and AI from The George Institute for Global Health under Professor Amanda Henry’s supervision, co-supervised by Associate Professor Rebecca Deans (from the Discipline of Women’s Health/School of Clinical Medicine) and Dr Oisin Fitzgerald, from the Centre for Big Data Research in Health.
Dr Heffernan-Marks’ extensive background in medicine, research, and technology, plus her first-hand experience of being dismissed and not believed with her health, drives her mission to address the gender health gap by developing innovative, women-centric health solutions that empower individuals and improve health outcomes for all.
Dr Heffernan-Marks has also been awarded as Woman in Digital of the Year, AI Leader of the Year 2025 and listed by the Sydney Morning Herald on the Female Trailblazer List 2026.
Chelsea Cornelius is CEO of Stratos MedTech and an MTAA Board Director. She leads PeriCoach, a clinically validated pelvic floor solution, and is passionate about advancing women’s health through scalable innovation that improves access and connects care pathways.
Joey Man is an Investment Associate at Tenmile, the dedicated health technology investment business owned by Tattarang. She brings a background in scientific research, venture capital and company formation, with experience across early-stage investing, commercial analysis, and strategic initiatives across Tenmile’s portfolio. She previously worked on company spinouts through the CSIRO Accelerator, and academic roles focused on breast cancer metastasis and stem cell biology.
Joey holds a PhD in Biochemistry and Molecular Biology from the Biomedicine Discovery Institute at Monash University.
Anthony Liveris is CEO of Proto Axiom, an Australian life sciences company-creator and investor that builds next-generation biotech firms from first experiment to scale. Proto Axiom partners with leading researchers to form, fund, and grow companies including Endo Axiom, SWAN Genomics, JumpStart Fertility, Onyx Axiom, and Advancell. Anthony serves as Chair of the St Vincent’s Hospital Discovery and Innovation Fund. He previously co-founded Applecart, a data platform serving Fortune-level clients, and held roles with Malcolm Turnbull, the Tony Blair Institute, and US policy campaigns. Anthony holds an MPP from the University of Oxford and a BA from the University of Pennsylvania.
12.30pm
Luncheon Start
12.40pm
10 mins
Luncheon Welcome, MTAA
Jasjit Baveja is Director of Regulatory and Industry Policy at MTAA, where she leads regulatory policy development and industry engagement with the Therapeutic Goods Administration. She brings over a decade of hands-on experience in medical device regulation.
A long-standing advocate for women in the medical technology industry, Jasjit has co-led women’s network employee resource groups at both Boston Scientific and Johnson & Johnson, and continues to champion gender diversity and inclusion across the sector through her work at MTAA.
12.50pm
50 mins
16
Luncheon Keynote
Grace Toombs is the founder of June Health, an Australian women’s health startup working to make cervical screening, STI testing and reproductive care more accessible, private and stigma-free. With a background in health and research, she combines clinical insight and lived experience to advocate for earlier intervention and better pathways into primary care for young women. Grace is passionate about challenging systemic gaps in healthcare and building bold, user-centred solutions that change how women engage with their health.
2.00pm
20 mins
Closing Remarks, MTAA
Jasjit Baveja is Director of Regulatory and Industry Policy at MTAA, where she leads regulatory policy development and industry engagement with the Therapeutic Goods Administration. She brings over a decade of hands-on experience in medical device regulation.
A long-standing advocate for women in the medical technology industry, Jasjit has co-led women’s network employee resource groups at both Boston Scientific and Johnson & Johnson, and continues to champion gender diversity and inclusion across the sector through her work at MTAA.
2.30pm
Luncheon ends
Day 2 End
Register Now
Early bird tickets include access to the Women’s Health Luncheon
